MedKoo Cat#: 564675 | Name: DSP-2230
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

DSP-2230 is a selective Nav1.7/Nav1.8 blocker.

Chemical Structure

DSP-2230
DSP-2230
CAS#1233231-30-5

Theoretical Analysis

MedKoo Cat#: 564675

Name: DSP-2230

CAS#: 1233231-30-5

Chemical Formula: C20H20F3N5O2

Exact Mass: 419.1569

Molecular Weight: 419.41

Elemental Analysis: C, 57.28; H, 4.81; F, 13.59; N, 16.70; O, 7.63

Price and Availability

Size Price Availability Quantity
5mg USD 110.00 Ready to ship
10mg USD 180.00 Ready to ship
25mg USD 385.00 Ready to ship
50mg USD 650.00 Ready to ship
100mg USD 1,050.00 Ready to ship
200mg USD 1,750.00 Ready to ship
500mg USD 3,050.00 Ready to ship
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
DSP2230; DSP 2230; DSP-2230
IUPAC/Chemical Name
(R)-2-(((3-Cyclobutyl-5-(3,4,5-trifluorophenoxy)-3H-imidazo[4,5-b]pyridin-2-yl)methyl)amino)propanamide
InChi Key
HHXCJIMPEJSJTG-SNVBAGLBSA-N
InChi Code
InChI=1S/C20H20F3N5O2/c1-10(19(24)29)25-9-16-26-15-5-6-17(27-20(15)28(16)11-3-2-4-11)30-12-7-13(21)18(23)14(22)8-12/h5-8,10-11,25H,2-4,9H2,1H3,(H2,24,29)/t10-/m1/s1
SMILES Code
C[C@@H](NCC1=NC2=CC=C(OC3=CC(F)=C(F)C(F)=C3)N=C2N1C4CCC4)C(N)=O
Appearance
Solid powder
Purity
>95% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Biological target:
DSP-2230 is a selective Nav1.7/Nav1.8 blocker.
In vitro activity:
TBD
In vivo activity:
TBD
Solvent mg/mL mM
Solubility
DMSO 125.0 298.04
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 419.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1. Bagal SK, Marron BE, Owen RM, Storer RI, Swain NA. Voltage gated sodium channels as drug discovery targets. Channels (Austin). 2015;9(6):360-6. doi: 10.1080/19336950.2015.1079674. PMID: 26646477; PMCID: PMC4850042. 2. Alsaloum M, Higerd GP, Effraim PR, Waxman SG. Status of peripheral sodium channel blockers for non-addictive pain treatment. Nat Rev Neurol. 2020 Dec;16(12):689-705. doi: 10.1038/s41582-020-00415-2. Epub 2020 Oct 27. PMID: 33110213. 3. Sara Sabina Hadida-Ruah, et al. Sulfonamides as modulators of sodium channels. https://patents.google.com/patent/WO2015010065A1